Concepedia

Roberta Caputo

RC

Statistics

Publications

15

Citations

1.4K

H-Index

13

Active since

2002

Affiliations

University of Naples Federico II(Current)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Roberta Caputo is an author at University of Naples Federico II specializing in medicine, oncology, and pharmacology.

Publications per year

2002–2025

15

Publications

15

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy

Fortunato Ciardiello, Roberto Bianco, Roberta Caputo et al. · Clinical Cancer Research · 2004 · 347 citations

, , +17

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano et al. · PubMed · 2003 · 329 citations

, , +17

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco et al. · PubMed · 2002 · 246 citations

, , +15

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models

Stefania Cocco, Alessandra Leone, Maria Serena Roca et al. · Journal of Translational Medicine · 2022 · 116 citations · Full text

, , +17

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Roberta Caputo, Giuseppe Buono, Michela Piezzo et al. · Frontiers in Oncology · 2024 · 73 citations · Full text

, , +17

1–5 of 15